MARKET

MRNA

MRNA

Moderna
NASDAQ
203.46
+6.18
+3.13%
After Hours: 202.90 -0.56 -0.28% 19:59 09/29 EDT
OPEN
197.78
PREV CLOSE
197.28
HIGH
208.90
LOW
190.00
VOLUME
13.28M
TURNOVER
--
52 WEEK HIGH
208.90
52 WEEK LOW
22.28
MARKET CAP
81.23B
P/E (TTM)
-25.4812
1D
5D
1M
3M
1Y
5Y
1D
Moderna Inc. Stock Climbs 3.1%, Outperforms Peers
Dow Jones · 7h ago
Moderna Sets Another Fresh 52-Week High: What's Happening?
Benzinga · 10h ago
Moderna And Merck: The Intismeran Readout That Was Worth $86 Billion
Seeking Alpha · 11h ago
These ten healthcare stocks posted the biggest September gains
Seeking Alpha · 16h ago
ValuEngine Weekly Commentary: Sector And ETF Performance
Seeking Alpha · 17h ago
AM Markets Need to Know: Trump rejects Iran report, AI risks, and more
Seeking Alpha · 17h ago
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)
TipRanks · 22h ago
Pfizer, BioNTech, Moderna dealt blow in effort to dismiss mRNA patent lawsuits
Seeking Alpha · 1d ago
More
About MRNA
Moderna, Inc. is a biotechnology company advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is engaged in developing medicines across infectious disease vaccines, oncology therapeutics and rare disease therapeutics. Its platform incorporates advances across three components, mRNA, delivery, and the manufacturing process, to advance its medicines. Its products are Spikevax and mNEXSPIKE (its COVID vaccines), and mRESVIA (its vaccine against respiratory syncytial virus (RSV)). It also has a diverse development pipeline that consists of 35 therapeutic and vaccine programs, six of which are in late-stage development. It has regulatory filings under review for its seasonal flu+COVID vaccine (mRNA-1083) in Europe and Canada and for its seasonal flu vaccine (mRNA-1010) in the United States, Europe, Canada and Australia. Its rare disease programs are Propionic acidemia (mRNA-3927); Methylmalonic acidemia (mRNA-3705), and Cystic Fibrosis (mRNA-3692/VX-522).

Webull offers Moderna Inc stock information, including NASDAQ: MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.